Prelude Therapeutics Inc
PRLD- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001678660
No open-market purchases or sales by Prelude Therapeutics Inc insiders were filed in the last 90 days; 75 institutions reported holding it in 13F filings for Q2 2026, worth $264.3M in total; no superinvestor holds it.
13F holders, Q1 2023
Institutional positions in Prelude Therapeutics Inc as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 55
- −5 vs. Q4 2022
- Shares held
- 31.5M
- +309.0K (+1.0%) vs. Q4 2022
- Total value
- $179.6M
- −$8.69M (−4.6%) vs. Q4 2022
- New holders
- 8
- 15 more added
- Sold out
- 13
- 15 more reduced
Compare with Q4 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting PRLD on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 75 | $264.3M |
| Q1 2026 | 55 | $105.2M |
| Q4 2025 | 48 | $82.6M |
| Q3 2025 | 47 | $39.1M |
| Q2 2025 | 50 | $22.0M |
| Q1 2025 | 59 | $23.3M |
| Q4 2024 | 62 | $41.0M |
| Q3 2024 | 70 | $74.0M |
| Q2 2024 | 61 | $129.2M |
| Q1 2024 | 58 | $162.1M |
| Q4 2023 | 56 | $148.3M |
| Q3 2023 | 60 | $113.1M |
| Q2 2023 | 55 | $176.2M |
| Q1 2023 | 55 | $179.6M |
| Q4 2022 | 60 | $188.3M |
| Q3 2022 | 53 | $210.3M |
| Q2 2022 | 62 | $170.9M |
| Q1 2022 | 68 | $235.4M |
| Q4 2021 | 75 | $437.6M |
| Q3 2021 | 61 | $1.12B |
| Q2 2021 | 57 | $986.6M |
| Q1 2021 | 60 | $1.41B |
Institutions, Q1 2023
Shares, value and share of portfolio for each institution holding Prelude Therapeutics Inc; share changes are against Q4 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| HighMark Wealth Management LLC | 50 | $285 | 0.00% | 00.0% | Unchanged |
| Bessemer Group Inc | 89 | $1.00K | 0.00% | 00.0% | Unchanged |
| Daiwa Securities Group Inc. | 104 | $1.00K | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 178 | $1.01K | 0.00% | −164−48.0% | Reduced |
| Advisor Group Holdings, Inc. | 500 | $2.85K | 0.00% | 00.0% | Unchanged |
| China Universal Asset Management Co., Ltd. | 649 | $3.70K | 0.00% | +279+75.4% | Added |
| UBS Group AG | 980 | $5.59K | 0.00% | −57−5.5% | Reduced |
| Point72 Asset Management, L.P. | 1,222 | $6.96K | 0.00% | +1,222 | New |
| JPMorgan Chase & Co | 1,394 | $8.00K | 0.00% | +97+7.5% | Added |
| Point72 Middle East FZE | 1,680 | $9.58K | 0.00% | +1,680 | New |
| Cutler Group LP | 2,130 | $12.0K | 0.00% | 00.0% | Unchanged |
| Nisa Investment Advisors, LLC | 4,000 | $23.0K | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 5,258 | $30.0K | 0.00% | +959+22.3% | Added |
| Denali Advisors LLC | 8,200 | $46.7K | 0.02% | 00.0% | Unchanged |
| Cubist Systematic Strategies, LLC | 8,778 | $50.0K | 0.00% | +8,778 | New |
| Barclays PLC | 10,322 | $58.8K | 0.00% | −80,502−88.6% | Reduced |
| Two Sigma Securities, LLC | 10,922 | $62.3K | 0.01% | +10,922 | New |
| Virtu Financial LLC | 11,201 | $64.0K | 0.01% | +11,201 | New |
| Dimensional Fund Advisors LP | 12,759 | $72.7K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 13,352 | $76.0K | 0.00% | +9,820+278.0% | Added |
| Boothbay Fund Management, LLC | 16,198 | $92.3K | 0.00% | −1,425−8.1% | Reduced |
| Northern Trust Corp | 21,167 | $120.7K | 0.00% | 00.0% | Unchanged |
| HRT Financial LP | 22,175 | $126.0K | 0.00% | +22,175 | New |
| Two Sigma Investments, LP | 22,455 | $128.0K | 0.00% | −29,443−56.7% | Reduced |
| Man Group plc | – | $129.2K | 0.00% | – | – |
| Bank of America Corp | 28,186 | $160.7K | 0.00% | −129,638−82.1% | Reduced |
| TD Asset Management Inc | 28,440 | $162.1K | 0.00% | 00.0% | Unchanged |
| 683 Capital Management, LLC | 28,631 | $163.2K | 0.01% | 00.0% | Unchanged |
| Qube Research & Technologies Ltd | 30,377 | $173.1K | 0.00% | +17,250+131.4% | Added |
| Manufacturers Life Insurance Company, The | 34,298 | $195.5K | 0.00% | 00.0% | Unchanged |
| Bridgeway Capital Management, LLC | 36,949 | $210.6K | 0.01% | 00.0% | Unchanged |
| State Street Corp | 43,889 | $250.2K | 0.00% | 00.0% | Unchanged |
| D. E. Shaw & Co., Inc. | 47,249 | $269.3K | 0.00% | −20,756−30.5% | Reduced |
| Gsa Capital Partners LLP | 47,614 | $271.0K | 0.03% | −187−0.4% | Reduced |
| Goldman Sachs Group Inc | 49,496 | $282.1K | 0.00% | +33,732+214.0% | Added |
| Two Sigma Advisers, LP | 50,500 | $287.9K | 0.00% | −24,800−32.9% | Reduced |
| Charles Schwab Investment Management Inc | 62,851 | $358.3K | 0.00% | −870−1.4% | Reduced |
| Jane Street Group, LLC | 64,470 | $367.5K | 0.00% | +47,663+283.6% | Added |
| Citigroup Inc | 70,767 | $403.4K | 0.00% | +10,695+17.8% | Added |
| Jacobs Levy Equity Management, Inc | 84,667 | $482.6K | 0.00% | +84,667 | New |
| State of Wisconsin Investment Board | 90,200 | $514.1K | 0.00% | −10,200−10.2% | Reduced |
| Susquehanna International Group, LLP | 129,680 | $739.2K | 0.00% | +36,390+39.0% | Added |
| Millennium Management LLC | 136,519 | $778.0K | 0.00% | +86,783+174.5% | Added |
| Renaissance Technologies LLC | 138,500 | $789.0K | 0.00% | +2,000+1.5% | Added |
| Morgan Stanley | 141,662 | $807.5K | 0.00% | +51,713+57.5% | Added |
| Geode Capital Management, LLC | 145,904 | $831.7K | 0.00% | +1,227+0.8% | Added |
| Price T Rowe Associates Inc | 284,362 | $1.62M | 0.00% | −16,315−5.4% | Reduced |
| BlackRock Inc. | 423,028 | $2.41M | 0.00% | +29,475+7.5% | Added |
| Massachusetts Financial Services Co | 514,548 | $2.93M | 0.00% | −423−0.1% | Reduced |
| Boxer Capital, LLC | 699,047 | $3.98M | 0.20% | +699,047 | New |
| Vanguard Group Inc | 916,014 | $5.22M | 0.00% | +16,700+1.9% | Added |
| UBS Asset Management Americas Inc | 2,273,894 | $13.0M | 0.01% | −62,050−2.7% | Reduced |
| FMR LLC | 4,546,678 | $25.9M | 0.00% | −42,914−0.9% | Reduced |
| OrbiMed Advisors LLC | 10,039,691 | $57.2M | 1.13% | 00.0% | Unchanged |
| Baker Bros. Advisors LP | 10,123,824 | $57.7M | 0.31% | 00.0% | Unchanged |
| Candriam Luxembourg S.C.A. | 0 | $0 | 0.00% | −179,850−100.0% | Sold out |
| New York Life Investment Management LLC | 0 | $0 | 0.00% | −82,000−100.0% | Sold out |
| Caxton Associates LP | 0 | $0 | 0.00% | −65,453−100.0% | Sold out |
| Bank of New York Mellon Corp | 0 | $0 | 0.00% | −28,879−100.0% | Sold out |
| Bleakley Financial Group, LLC | 0 | $0 | 0.00% | −22,325−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −18,232−100.0% | Sold out |
| Mirabella Financial Services LLP | 0 | $0 | 0.00% | −16,058−100.0% | Sold out |
| Commonwealth Equity Services, LLC | 0 | $0 | 0.00% | −15,307−100.0% | Sold out |
| Dark Forest Capital Management LP | 0 | $0 | 0.00% | −3,092−100.0% | Sold out |
| Rockefeller Capital Management L.P. | 0 | $0 | 0.00% | −2,512−100.0% | Sold out |
| Quantbot Technologies LP | 0 | $0 | 0.00% | −800−100.0% | Sold out |
| FNY Investment Advisers, LLC | 0 | $0 | 0.00% | −200−100.0% | Sold out |
| Federated Hermes, Inc. | 0 | $0 | 0.00% | −65−100.0% | Sold out |